Patents by Inventor Xiaoxia Wen

Xiaoxia Wen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070196275
    Abstract: Conjugate molecules comprising a ligand bonded to a polymer are disclosed. One such conjugate molecule comprises a ligand bonded to a polymer, a chelating agent bonded to the polymer, and a radioisotope chelated to the chelating agent. The conjugate molecules may be useful in detecting and/or treating tumors or biological receptors. These conjugate molecules may be synthesized without the necessity of preactivation of the ligand using an SCN-polymer-chelating agent precursor. Conjugate molecules incorporating an annexin V ligand are particularly useful for visualizing apoptotic cells. Conjugate molecules incorporating a C225 ligand are particularly useful for targeting tumors expressing EGFR.
    Type: Application
    Filed: February 9, 2007
    Publication date: August 23, 2007
    Inventors: Chun Li, Xiaoxia Wen, Qing-Ping Wu, Sidney Wallace, Lee Ellis
  • Publication number: 20050152842
    Abstract: The present invention includes PG polymer complexes with paramagnetic materials, such as Gd, Mn and iron oxide. The complexes may also include chelating agents which may be covalently attached to the PG polymer backbone through linkers. PEG may also be attached to the PG polymer backbone. The complexes may include targeting molecules. The complexes are useful as MRI contrast agents, particularly as blood pool agents.
    Type: Application
    Filed: December 22, 2004
    Publication date: July 14, 2005
    Inventors: Chun Li, Xiaoxia Wen, Edward Jackson, Sidney Wallace
  • Publication number: 20030003048
    Abstract: Conjugate molecules comprising a ligand bonded to a polymer are disclosed. One such conjugate molecule comprises a ligand bonded to a polymer, a chelating agent bonded to the polymer, and a radioisotope chelated to the chelating agent. The conjugate molecules may be useful in detecting and/or treating tumors or biological receptors. These conjugate molecules may be synthesized without the necessity of preactivation of the ligand using an SCN-polymer-chelating agent precursor. Conjugate molecules incorporating an annexin V ligand are particularly useful for visualizing apoptotic cells. Conjugate molecules incorporating a C225 ligand are particularly useful for targeting tumors expressing EGFR.
    Type: Application
    Filed: April 19, 2002
    Publication date: January 2, 2003
    Inventors: Chun Li, Xiaoxia Wen, Qing-Ping Wu, Sidney Wallace, Lee M. Ellis